Use of circulating exosomal long non-coding RNA-tc0101441 as a marker for the diagnosis of endometriosis
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE OBSTETRICS & GYNECOLOGY HOSPITAL OF FUDAN UNIV
- Publication Date
- 2021-05-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medical detection, and relates to a serum and cell supernatant exosome lncRNA-TC0101441, specifically circulating exosome long-chain non-coding RNA-TC0101441 as a biomarker for diagnosing endometriosis and use in diagnostic reagents. Background technique
[0002] Endometriosis (EMs, referred to as "endometriosis") is an aggressive, estrogen-dependent disease characterized by the presence of endometrial glands and stroma in other parts of the uterus . The main clinical manifestations of endometriosis are pain and infertility, which seriously affect the quality of life of women. Endometriosis affects 10%-15% of reproductive-age women worldwide and more than 70 million people. Mild lesions of endometriosis may have tiny lesions on the surface of the organs, and severe lesions may lead to extensive adhesions of the bowel, bladder, and ureter in the pelvic organs.
[0003] Laparoscopy is not practical as an invasive...